Covex S.A. | Covex S.A.

A Spanish chemical-pharmaceutical company specialized in vinca-derived alkaloids, manufacturing high-quality NCF (GMP) certified APIs (Vinpocetine, Vincamine and Vinburnine) for the global pharmaceutical industry. Its ingredients are derived from African Voacanga and are processed using high-tech equipment compliant with ICH standards, supported by a GMP-certified manufacturing site and GMP-certified laboratory, with EU authorization as a drug manufacturer/importer certified by AEMPS.

As a CMO/CDMO partner, the company provides end-to-end support combining manufacturing, packaging, analytical control and regulatory traceability. Since 2020, its pharmaceutical plant is fully operational for finished dosage forms and nutraceuticals, offering tablet compression (uncoated), primary packaging (Alu/PVC and Alu/Alu blisters, thermo-sealed bottles with labeling), secondary packaging (cartoning/re-cartoning/labeling), and serialization connected to EMVO via TraceLink®.

The company also delivers a broad third-party services portfolio: a state-of-the-art QC laboratory (physico-chemical testing, method development/validation/transfer, dose uniformity, dissolution, related substances, water testing, and ICH/on-going stability studies), manufacturing services (pharmaceutical and chemical), and a full import service to support projects from development through market supply.